VS
Vivek Sureshchandra Saxena
About Vivek Sureshchandra Saxena
Data last updated:
Vivek Sureshchandra Saxena was a Director at I-Res India Private Limited (2022–2025), Director at Natturz Bio Kontrol Private Limited (2023–2024) and Director at Tesia Dairy Private Limited (2022–2023), and held 1 more directorship. The companies operate in Healthcare, Travel and Hospitality and Food And Beverages.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 I-Res India Private Limited U33100MP2022PTC063276 | Director | 20 Dec 2022 | 2022 | ₹1.9 Lakh (FY 2025) | Active |
| Natturz Bio Kontrol Private Limited U15100DL2018PTC332430 | Director | 28 Aug 2023 | 2018 | ₹1.6 Lakh (FY 2024) | Active |
| Tesia Dairy Private Limited U15490GJ2020PTC116522 | Director | 24 Jan 2022 | 2020 | ₹3.73 Cr (FY 2025) | Active |
| Vaas Synergies (Opc) Private Limited U74999UP2019OPC123208 | Director | 08 Nov 2019 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Sureshchandra Saxena
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Sureshchandra Saxena
Vivek Sureshchandra Saxena was first appointed on 08 Nov 2019 as Director at Vaas Synergies (Opc) Private Limited. The most recent appointment on record is 28 Aug 2023 at Natturz Bio Kontrol Private Limited.
Vivek Sureshchandra Saxena held 4 earlier board appointments: I-Res India Private Limited (Director, 20 Dec 2022 to 26 Jun 2025); Natturz Bio Kontrol Private Limited (Director, 28 Aug 2023 to 04 Jul 2024); Tesia Dairy Private Limited (Director, 24 Jan 2022 to 30 Nov 2023); Vaas Synergies (Opc) Private Limited (Director, 08 Nov 2019 to 02 Mar 2021).